Buscar resultados de ensayos clínicos
Pseudomonas Infections - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin Condición: Pseudomonas Infections Fecha: 2008-03-04 Intervenciones:
|
Completed |
Nombre del estudio: Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa Condición:
Intervenciones: |
Completed |
Nombre del estudio: Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections Condición: Pseudomonas Aeruginosa Infection Fecha: 2011-03-14 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection Condición: Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa Fecha: 2014-03-06 Intervenciones: Drug: Tobramycin |
Completed |
Nombre del estudio: Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways Condición:
Fecha: 2011-07-26 Intervenciones: Drug: AZLI AZLI 75 mg was administered 3 times daily via the investigational nebulizer. |
Completed |
Nombre del estudio: Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization Condición:
Fecha: 2009-12-17 Intervenciones: Drug: Colistin Sino-Nasal inhalation, approximately 1 ml / day in each nostril |
Completed |
Nombre del estudio: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 Condición: Pseudomonas Infection Fecha: 2009-05-28 Intervenciones: Drug: Ciprofloxacin (Cipro, BAYQ3939) 25 mg inhaled Ciprofloxacin |
Completed |
Nombre del estudio: Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers Condición: Healthy Fecha: 2008-10-22 Intervenciones:
|
Terminated |
Nombre del estudio: Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa Condición: Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis Fecha: 2014-09-22 Intervenciones: Drug: TIS or TIP 300mg nebulized Tobramycin (Tobramycin inhalation solution(TIS)) or TOBI Podhaler (Tobr |
Approved for marketing |
Nombre del estudio: Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Condición:
Intervenciones: Drug: Aztreonam Lysine for Inhalation 75 mg three times a day via inhalation for 28 days followed by 28 |